Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
Rosuvastatin
Matrix: | Human Plasma |
Assay Range: | 50 - 15,000 pg/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Rosuvastatin in presence of Aspirin and Salicylic acid
Matrix: | Human Plasma |
Assay Range: | 0.2 - 70 ng/mL |
Sample Volume: | 0.4 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
S-100B
Matrix: | Human Serum |
Assay Range: | 50 - 2,000 pg/mL |
Sample Volume: | 0.06 mL |
Anti-Coagulant: | N/A |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
S-Amlodipine
Matrix: | Human Plasma |
Assay Range: | 50 - 15,000 pg/mL |
Sample Volume: | 0.3mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Salicylic Acid in presence of Aspirin
Matrix: | Human Plasma |
Assay Range: | 200 - 14,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | NSAID |
Classification: | Drug Assays |
Saxagliptin 5-OH-Saxagliptin in presence of Dapagliflozin
Matrix: | Human Plasma |
Assay Range: | 0.4 - 100 ng/mL 0.8 - 200 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Saxagliptin 5-OH-Saxagliptin in presence of Metformin
Matrix: | Human Plasma |
Assay Range: | 0.4 - 100 ng/mL 0.8 - 200 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC-MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Scopolamine
Matrix: | Human Plasma |
Assay Range: | 5 - 5,000 pg/mL |
Sample Volume: | 0.15 mL |
Anti-Coagulant: | K2 EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiemetic |
Classification: | Drug Assays |
Sertraline
Matrix: | Human Plasma |
Assay Range: | 0.2 - 200 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antidepressant |
Classification: | Drug Assays |
Sertraline
Matrix: | Human Plasma |
Assay Range: | 0.2 - 20 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Antidepressant |
Classification: | Drug Assays |
Sertraline
Matrix: | Human Plasma |
Assay Range: | 0.2 - 200 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antidepressant |
Classification: | Drug Assays |
Sertraline
Matrix: | Human Plasma |
Assay Range: | 0.2 - 80 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antidepressant |
Classification: | Drug Assays |
Serum Amyloid A (SAA)
Matrix: | Human Plasma |
Assay Range: | 0.0696 - 218 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | ECL (MSD) |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
SHBG
Matrix: | Human Serum |
Assay Range: | 2 - 180 nmol/L |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | Immulite |
Site: | QPS-NL |
CLIA: | |
Therapy Area: | |
Classification: | Biochemical Biomarkers |
Sildenafil
Matrix: | Human Plasma |
Assay Range: | 1 - 1000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Sodium Heparin |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Vasodilator |
Classification: | Drug Assays |
SildenafilN-Desmethyl Sildenafil
Matrix: | Human Plasma |
Assay Range: | 5 - 1,500 ng/mL 5 - 700 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Vasodilator |
Classification: | Drug Assays |
SildenafilN-Desmethyl Sildenafil
Matrix: | Human Plasma |
Assay Range: | 1 - 1,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Vasodilator |
Classification: | Drug Assays |
Silver
Matrix: | Formulation |
Assay Range: | 10.0 - 1,000 ng/mL |
Sample Volume: | 125 µL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | 2 - 8 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Drug Assays |
Silver
Matrix: | Solid Samples |
Assay Range: | 10.0 - 1,000 ng/mL |
Sample Volume: | 250 mg |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | 2 - 8 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Drug Assays |
Simvastatin
Simvastatin Acid
Simvastatin Acid
Matrix: | Human Plasma |
Assay Range: | 0.05 - 10 ng/mL 0.02 - 4 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Simvastatin
Simvastatin Hydroxy Acid
Simvastatin Hydroxy Acid
Matrix: | Human Plasma |
Assay Range: | 0.250 - 75 ng/mL 0.2 - 50 ng/mL |
Sample Volume: | 0.25 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Simvastatin
Simvastatin Hydroxy Acid
Simvastatin Hydroxy Acid
Matrix: | Human Plasma |
Assay Range: | 0.250 - 125 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Simvastatin
Simvastatin Hydroxy Acid
Simvastatin Hydroxy Acid
Matrix: | Human Plasma |
Assay Range: | 0.05 - 25 ng/mL 0.02 - 10 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | LC-MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Sirolimus
Matrix: | Human Whole Blood |
Assay Range: | 0.2 - 100 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Immunosuppressant |
Classification: | Drug Assays |
Sirolimus
Matrix: | Human Whole Blood |
Assay Range: | 0.5 - 60 ng/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Immunosuppressant |
Classification: | Drug Assays |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT